Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
39
pubmed:dateCreated
2004-9-20
pubmed:abstractText
The promyelocytic leukemia gene (PML) encodes a growth/tumor suppressor protein that is essential for the induction of apoptosis in response to various apoptotic signals. The mechanism by which PML plays a role in the regulation of cell death is still unknown. In the current study, we demonstrate that PML negatively regulated the SAPK2/p38 signaling pathway by sequestering p38 from its upstream kinases, MKK3, MKK4, and MKK6, whereas PML did not affect the SAPK1/c-Jun NH(2)-terminal kinase pathway. PML associated with p38 both in vitro and in vivo and the carboxyl terminus of PML mediated the interaction. In contrast to other studies of PML and PML-nuclear bodies (NB), our study shows that the formation of PML-NBs was not required for PML to suppress p38 activity because PML was still able to bind and inhibit p38 activity under the conditions in which PML-NBs were disrupted. In addition, we show that the promotion of Fas-induced cell death by PML correlated with the extent of p38 inhibition by PML, suggesting that PML might regulate apoptosis through manipulating SAPK2/p38 pathways. Our findings define a novel function of PML as a negative regulator of p38 kinase and provide further understanding on the mechanism of how PML induces multiple pathways of apoptosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD95, http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Calmodulin-Dependent..., http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Glutathione Transferase, http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles, http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase 3, http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase 6, http://linkedlifedata.com/resource/pubmed/chemical/MAP2K3 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/MAP2K6 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase..., http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Proteins, http://linkedlifedata.com/resource/pubmed/chemical/PML protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/SB 203580, http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins, http://linkedlifedata.com/resource/pubmed/chemical/p38 Mitogen-Activated Protein...
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0021-9258
pubmed:author
pubmed:copyrightInfo
Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.
pubmed:issnType
Print
pubmed:day
24
pubmed:volume
279
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
40994-1003
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:15273249-Antigens, CD95, pubmed-meshheading:15273249-Apoptosis, pubmed-meshheading:15273249-Calcium-Calmodulin-Dependent Protein Kinases, pubmed-meshheading:15273249-Cell Death, pubmed-meshheading:15273249-Cell Line, pubmed-meshheading:15273249-Cell Nucleus, pubmed-meshheading:15273249-Dose-Response Relationship, Drug, pubmed-meshheading:15273249-Enzyme Inhibitors, pubmed-meshheading:15273249-Flow Cytometry, pubmed-meshheading:15273249-Gene Expression Regulation, pubmed-meshheading:15273249-Glutathione Transferase, pubmed-meshheading:15273249-HeLa Cells, pubmed-meshheading:15273249-Humans, pubmed-meshheading:15273249-Imidazoles, pubmed-meshheading:15273249-MAP Kinase Kinase 3, pubmed-meshheading:15273249-MAP Kinase Kinase 6, pubmed-meshheading:15273249-Microscopy, Fluorescence, pubmed-meshheading:15273249-Mitogen-Activated Protein Kinase Kinases, pubmed-meshheading:15273249-Mitogen-Activated Protein Kinases, pubmed-meshheading:15273249-Neoplasm Proteins, pubmed-meshheading:15273249-Nuclear Proteins, pubmed-meshheading:15273249-Phosphorylation, pubmed-meshheading:15273249-Plasmids, pubmed-meshheading:15273249-Protein Binding, pubmed-meshheading:15273249-Protein Structure, Tertiary, pubmed-meshheading:15273249-Protein-Tyrosine Kinases, pubmed-meshheading:15273249-Pyridines, pubmed-meshheading:15273249-Signal Transduction, pubmed-meshheading:15273249-Transcription Factors, pubmed-meshheading:15273249-Transfection, pubmed-meshheading:15273249-Tumor Suppressor Proteins, pubmed-meshheading:15273249-Ultraviolet Rays, pubmed-meshheading:15273249-p38 Mitogen-Activated Protein Kinases
pubmed:year
2004
pubmed:articleTitle
Promyelocytic leukemia is a direct inhibitor of SAPK2/p38 mitogen-activated protein kinase.
pubmed:affiliation
College of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't